Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
F-18 FPCIT PET in Parkinson's Disease and Essential Tremor
NCT00468078Phase 3Completed
- Sponsor
- Asan Medical Center
- Start
- Nov 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Ioflupane F-18 in Parkinson's disease (PD), sponsored by Asan Medical Center. Started Nov 2006; status: completed.
02
Drugs
Ioflupane F-18
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00468078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00468078.